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Thermoresponsive hydrogel maintains the mouse embryonic stem 
cell “naïve” pluripotency phenotype  
Christian Mangani,
a 
Annamaria Lilienkampf,
a
 Marcia Roy,
b
 Paul A. de Sousa,
c,
* and Mark Bradley
a,
* 
A chemically defined thermoresponsive hydrogel, poly(AEtMA-Cl-
co-DEAEA) cross-linked with N,N’-methylenebisacrylamide, which 
allows enzyme-free passaging, was used as a substrate to culture 
mESCs under defined and undefined conditions. Analysis of 14 
stem cell markers showed that the mESCs remained in a “naïve” 
state of pluripotency with differentiation potential to form 
endoderm, mesoderm, and ectoderm derived lineages. These 
results validate the use of a chemically defined hydrogel for 
standardised and inexpensive mESC culture. 
Due to their multi-lineage potential, embryonic stem cells 
(ESCs) have immense therapeutic potential for the 
regeneration of cells and tissues. ESCs are isolated from the 
inner cell mass of blastocysts and have the potential to self-
renew indefinitely with the ability to differentiate into specific 
cell lineages provided that suitable culture conditions are 
provided.
1
 For their maintenance and growth, ESCs require a 
suitable substrate onto which cells can adhere, while cytokines 
in the culture media provide appropriate signalling cues for 
self-renewal. 
Research has predominately focused onto two types of ESCs, 
mouse (mESC) and human (hESC), although they display 
different states of pluripotency. mESCs extracted from the pre-
implantation blastocysts exist in the so-called “naïve” state,
2
 
whereas hESCs isolated from similarly staged embryos are 
described as existing in "primed" state, which differs in growth 
factor dependence and signal transduction pathway activity 
necessary to maintain an undifferentiated state.
3
 A primed 
state of pluripotency in humans is comparable to that 
exhibited by mouse post-implantation embryo epiblast derived 
stem cell populations (mEpiSC).
2a,4
 Both the “naïve” and 
“primed” state phenotypes can be classified as pluripotent as 
they are Oct-4, Nanog, and Sox-2 positive.
2a
 mESCs are further 
characterised by the additional “naïve” state markers  KLF4, 
Rex-1, FGF4, Essrb, Dax1, and Tbx3, whereas mEpiSCs express 
FGF5, nodal, Gata6, Sox-17 and Brachyury.
2d,4,5
 mESCs respond 
to LIF/STAT3 signalling and are typically grown on gelatin in 
serum with leukaemia inhibitory factor (LIF) or in serum-free 
media with LIF and GSK-3β and MAPK/ERK inhibitors  (so called 
2i media).
2c,3,6 
mEpiSCs, which are also cultured on gelatin, 
respond to FGF/Activin A/nodal signalling pathway.
3
 hESCs, 
also respond to FGF/Activin A/nodal signalling pathway but are 
typically grown on Matrigel™ in serum free media with growth 
factors, basic fibroblast growth factor (BFGF) and transforming 
growth factor beta (TGFβ).
4,7
 hESCs can be converted to the 
naïve state of pluripotency responding to LIF/STAT3 signalling 
by the use of LIF, GSK-3β and MAPK/ERK inhibitors, and 
Forskolin (adenyl cyclase activator).
8,9
 In the “naïve” state, 
hESCs have a higher capacity for differentiation into 
endoderm.
9
 
Their availability, “naïve” state phenotype, and the ease of 
producing genetically manipulated phenotypes make mESCs 
good models in embryology, in research for genetic disorders, 
and cancer.
4,10
 For example, both mESCs and hESCs can 
produce teratomas, and during differentiation they undergo 
chromatin changes altering accessibility to e.g. developmental 
genes like HoxB locus, a process that also occurs during cancer 
development.
11
 Although mESCs cannot be applied in 
regenerative medicine, they can be used as a readily available 
cell line for developing protocols and applications for hESCs. 
For example, dopamine-producing neurons have been 
generated from mESCs and subsequently used to produce 
neurons in dopamine deficient rodents.
12
   
The maintenance and expansion of mESCs and hESCs in vitro 
remains a challenge. To replace animal derived gelatin or 
Matrigel™, research has focused on the identification of 
synthetic substrates, such as polymer and peptide-based 
materials, to allow more defined culture systems.
13
 The self-
renewal and differentiation potential of ESCs is determined by 
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both the physical (e.g. stiffness, roughness) and chemical 
properties (e.g. charge, hydrophilicity) of these materials.
14
 
Polymer-based materials also have potential as 3D scaffolds 
and they can be modified to release or immobilise bioactive 
molecules such as peptides and cytokines, which can control 
stem cell fate.
14b
 Many examples of polymers as substrates for 
ESCs exist; however, they often rely on the addition of 
adhesion proteins, such as fibronectin and vitronectin, and 
require enzymatic or mechanical treatment for passaging.
15 
Hydrogels are attractive substrates for ESCs as their structure 
can be tuned to be biocompatible with thermo-responsive 
properties.
16
 Mouse embryonic fibroblasts have been cultured 
on 3D poly(N-isopropylacrylamide) microbeams, which upon 
temperature reduction undergo swelling thus releasing the 
cells.
17
 Recently, we reported a hydrogel HG21 (Fig. 1), a 
copolymer 2-(acryloyloxyethyl) trimethylammonium chloride 
(AEtMA-Cl) and 2-(diethylamino)ethyl acrylate (DEAEA) (with 
the cross-linker N,N’-methylenebisacrylamide), which 
supported long-term culture (>20 passages) of hESCs in serum-
free media without the addition of adhesion proteins.
13a
 
Furthermore, this hydrogel allowed gentle, enzyme free 
passaging via thermo-modulation.  Here, the hydrogel HG21 
was investigated as a substrate for mESCs with the cells 
evaluated for “naïve” and “primed” state markers.  
The first objective of the study was to verify whether HG21 
had the ability to support growth of mESCs in their naïve state 
of pluripotency. mESC cell lines HM1 and E14TG2a were grown 
on HG21 in undefined (serum-supplemented GMEM) and 
defined (serum-free 2i media) conditions, respectively. For the 
cells on HG21, thermo-detachment (15 °C for 30 minutes) was 
used for passaging, while the control cells on gelatin required 
enzymatic passaging (trypsin/EDTA). The cells were maintained 
for 5 passages during which the mESCs cultured on HG21 grew 
with “dome shaped” morphology (a characteristic of mESCs) 
similar to the cells on gelatin (ESI Fig. S1).  
After continuous culture for 5 passages on HG21 in undefined 
or defined media, the pluripotency of the mESCs was 
investigated by immunostaining for the markers Oct-4 and 
Nanog (the key regulators for pluripotency in all ESCs), and for 
SSEA-1 (stage-specific embryonic antigen 1, also known as 
CD15 or Lewis
X
), a specific surface pluripotency marker for 
mESCs. SSEA-1 is a cell surface carbohydrate antigen, which is 
involved in cell–cell interactions during development and is 
strongly expressed in mouse embryos at the pre-implantation 
stage and in undifferentiated mESCs in which it is involved in  
  
Fig. 1 HG21 is a random copolymer of 2-(acryloyloxyethyl) trimethylammonium 
chloride (AEtMA-Cl) and 2-(diethylamino)ethyl acrylate (DEAEA) polymerised in a 3:1 
monomer ratio, respectively, with 5% of N,N’-methylenebisacrylamide as a crosslinker. 
the formation of compact colonies.
18 
Immunostaining and 
fluorescent imaging of the mESCs, both in undefined and in 
defined culture, showed the clear presence of Oct-4 and 
Nanog on cells grown on both HG21 and gelatin, proving that 
HG21 maintained mESCs in a pluripotent state (Fig. 2). Flow 
cytometry analysis of the mESCs maintained in undefined  
 
Fig. 2 Immunostaining of mESCs cultured on HG21 or gelatin for pluripotency markers 
Oct-4 and Nanog (Scale bar = 50 µm). (A) HM1 mESCs in undefined, serum-based 
culture stained for DAPI (blue, λEx/Em 364/454 nm), (c–d) Oct-4 (green, λEx/Em 490/525 
nm), (e–f) Nanog (red, λEx/Em 555/580 nm). (B) Immunostaining of E14TG2a mESCs in 
defined, serum-free culture stained for (a–b) DAPI (blue), (c–d) Oct-4 (green), (e–f) 
Nanog (red). 
 
Fig. 3 Flow cytometry analysis (λEx/λEm 488/575 nm, n = 3) of SSEA-1 expression on 
mESCs  (passage 5) cultured on HG21 (thermo-detachment) or gelatin (trypsination). 
(A) The percentage of SSEA-1 positive cells in undefined, serum-based culture (HM1) 
and in defined, serum-free culture (E14TG2a). (B) Representative flow cytometry 
histograms (x-axis = fluorescence intensity). The population stained for SSEA-1 is shown 
in red and the grey line represents unstained population.  
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media showed high levels of SSEA-1 (80% on HG21, 96% on 
gelatin, n = 3) (Fig. 3, ESI Fig. S2A). mESCs cultured on HG21 in 
defined media showed high expression of SSEA-1 (85%); 
however,the cells cultured on gelatin showed a notably lower 
marker expression (39%) (Fig. 3, ESI Fig. S2B). The apparent 
low expression of SSEA-1 on mESCs on gelatin may be partly 
attributed to the use of trypsin passaging, which is likely to 
remove/damage cell surface markers particularly in defined 
culture, which lacks serum protecting factors (protease 
inhibitors, α1-antitrypsin) against trypsin. This highlights the 
potential advantage of the thermo-detachment protocol, 
where the mESCs are passaged with minimum interference 
allowing better recovery after passaging. 
To further explore the pluripotency of mESCs and to determine 
if the cells had remained in the naïve state during culture on 
HG21, the cells were analysed for pluripotency and naïve state 
gene markers by qPCR.  At passage 5, RNA was isolated from 
the mESCs and the corresponding cDNA amplified for 
pluripotency markers Oct-4, Nanog, and Sox-2, and naïve state 
markers KLF4, Rex1, Tbx3, Essrb, Dax1, and FGF4. In addition, 
the expression of differentiation/mEpiSC state markers Nodal, 
FGF5, Gata6, Sox17, and Brachyury was investigated. qPCR 
analysis showed that the pluripotency and naïve markers were 
present on the cells grown both on gelatin and HG21, both in 
undefined and defined conditions, as shown by the expression  
 
 
Fig. 4 qPCR analysis of pluripotency mRNA in mESCs cultured on HG21 and gelatin 
normalised to GAPDH (quantified as 2
-ΔCt
) (biological samples n = 3, PCR replicates n = 
3). (A) Undefined, serum-based culture. (B) Defined, serum-free culture (****p ≤ 
0.0001; ***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05).  
of pluripotency markers Oct-4, Sox-2 and Nanog, and naïve 
markers KLF4, Rex1, Esrrb, Dax1, Tbx3, and FGF4 (Fig. 4). 
Nanog and Oct-4 are known to actively target transcribing 
genes promoting the naïve state,
19
 especially Nanog, which is 
central in defining mESC pluripotency, is known to target Rex1 
and Esrrb for activation,
20
 which are further augmented by 
Oct-4 and Sox-2.
20b
 These naïve markers along with the 
pluripotency markers were in fact higher in mESCs cultured on 
defined, serum-free media (Fig. 4B).
 
The cells showed low expression of differentiation/mEpiSC 
markers FGF5, Gata6, Sox17, and Brachyury, especially under 
defined culture. Nodal, although at a low expression levels, 
was present on cells cultured both under undefined and 
defined conditions, as autocrine endogenous activity of Nodal 
may promote mESC propagation.
21 
The gene expression profile 
of mESCs in defined culture showed a significantly higher 
expression of Oct-4, and Nanog on HG21 compared to cells 
grown on gelatin (Figure 4B). Similarly in defined culture, 
expression of naïve markers KLF4, Rex1, Essrb, Tbx3, and FGF4 
was significantly higher on HG21 compared to the mESCs 
grown on gelatin. The high levels of these genes in mESCs 
grown on HG21, implies that the substrate is better than 
gelatin in maintaining pluripotency and the cells are more 
actively transcribing genes involved in the naïve state of 
pluripotency than genes involved in differentiation. Under 
defined conditions, as there is no interference from the serum 
component, the differences in marker expressions were more 
evident between the two substrates compared to the mESCs 
grown in undefined conditions. The relative expression of the 
pluripotency and naïve state genes is higher in defined serum-
free culture, which may have interesting implications for 
future work with induced naïve hESC.  
After 5 passages on HG21 in undefined media, the mESCs were 
selectively differentiated into endoderm, mesoderm, and 
ectoderm. After embryoid body formation, treatment with 
Activin A, Activin A with BMP4, or retinoic acid induced 
endoderm, mesoderm, and ectoderm formation, respectively. 
Immunostaining for α-fetoprotein (marker for endoderm), α-
smooth muscle (mesoderm), and early neural marker nestin
22
 
(ectoderm) confirmed that the mESCs cultured on HG21 had 
maintained their pluripotent potential to differentiate into all 
the three lineages (Fig. 5). Overall, the degree of 
differentiation was comparable to cells grown on gelatin; 
however, relative quantification of the differentiation 
suggested better endoderm formation with the cells grown on 
gelatin (ESI Fig. S3).   
Conclusions 
HG21 was able to sustain mESCs culture while allowing gentle 
passaging without the use enzymatic treatment, whilst 
keeping mESCs in the naïve state of pluripotency – in effect, 
HG21 is a replacement for gelatin in mESC culture. The 
maintenance of the naïve state phenotype on HG21 was 
proven by qPCR analysis of 14 genes involved in pluripotency 
and naïve and  
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Fig. 5 Immunostaining of HM1 mECSs cultured on HG21 and gelatin after selective 
differentiation into endoderm, mesoderm and ectoderm. (a–b) Endoderm stained for 
DAPI (blue, λEx/Em 364/454 nm) and α-fetoprotein (green, λEx/Em 490/525 nm), (c–d) 
Mesoderm stained for DAPI (blue) and α-smooth muscle (red, λEx/Em 555/580 nm), (e–f) 
Ectoderm stained for DAPI (blue) and Nestin (green, λEx/Em 490/525 nm). Scale bar = 20 
µm.  
primed states. In undefined culture on HG21, the appropriate 
markers were expressed in levels comparable to mESCs grown 
on gelatin, whereas in defined serum-free culture, the 
expression levels were higher on HG21 for pluripotency and 
primed state markers compared to gelatin. To fully determine 
the naïve state of these mESCs, future characterisation should 
include teratoma or chimera formation and epigenetic testing 
(X inactivation chromosome profile).  
HG21 was originally developed as a substrate for long-term 
hESC culture. The substrate inarguably plays an important role 
in the maintanence of both the “primed” hESCs and “naïve 
mESCs”; however, the naïve and primed states also rely on 
specific cytokines that are required in maintaining these 
phenotypes. Depending what culture conditions are used, 
specific signalling pathways are activated and the cells can be 
driven either towards the naïve or primed state. Since HG21 
supported the naïve phenotype of mESCs, it would be 
interesting to investigate whether HG21 supports hESCs in 
their naïve like state under defined conditions, since it is in this 
state that hESCs undergo more robust differentiation.  
Acknowledgements 
We thank Strategic Educational Pathways Scholarship Scheme 
(Malta) and the European Union European Social Fund for 
funding C.M., Drs Kay Samuel and Martin Waterfall for help 
with the flow analysis, and Drs Cairnan Duffy, Paz Freile and 
Eirni Koutsouraki for the help with experiment design, staining 
and qPCR, and Matthew Simmonte for the help with image 
analysis.   
Notes and references 
 
1 (a) L. A. Fortier, Vet. Surg., 2005, 34, 415; (b) A. K. Saxena, D. 
Singh, and J. Gupta, J. Exp. Ther. Oncol., 2010, 8, 223 
2 (a) J. Nichols and A. Smith, Cell Stem Cell, 2009,4, 487; (b) S. 
Ye, D. Liu, and Q.-L. Ying, Curr. Opin. Genet. Dev., 2014, 28C, 
10; (c) Q.-L. Ying, J. Wray, J. Nichols, L. Batlle-Morera, B. 
Doble, J. Woodgett, P. Cohen, and A. Smith, Nature, 2008, 
453, 519; (d) I. G. M. Brons, L. E. Smithers, M. W. B. Trotter, 
P. Rugg-Gunn, B. Sun, S. M. Chuva de Sousa Lopes, S. K. 
Howlett, A. Clarkson, L. Ahrlund-Richter, R. a Pedersen, and 
L. Vallier, Nature, 2007, 448, 191; (e) S. Pauklin, R. a 
Pedersen, and L. Vallier, J. Cell Sci., 2011, 124, 3727 
3 B. Greber, G. Wu, C. Bernemann, J. Y. Joo, D. W. Han, K. Ko, 
N. Tapia, D. Sabour, J. Sterneckert, P. Tesar, and H. R. 
Schöler, Cell Stem Cell, 2010, 6, 215 
4 J. Nichols and A. Smith, Development, 2011, 138, 3 
5 (a) P. J. Tesar, J. G. Chenoweth, F. a Brook, T. J. Davies, E. P. 
Evans, D. L. Mack, R. L. Gardner, and R. D. G. McKay, Nature, 
2007, 448, 196; (b) H. Zhou, W. Li, S. Zhu, J. Y. Joo, J. T. Do, 
W. Xiong, J. B. Kim, K. Zhang, H. R. Schöler, and S. Ding, J. 
Biol. Chem., 2010, 285, 29676; (c)  T. Kalkan, A. Smith, and P. 
T. R. S. B, Philos. Trans. R. Soc. Lond. B. Biol. Sci., 369, 
20130540. http://dx.doi.org/10.1098/rstb.2013.0540  
(d) K. Xue, J.-H. Ng, and H.-H. Ng, Philos. Trans. R. Soc. Lond. 
B. Biol. Sci., 2011, 366, 2238 
6 C. Tamm, S. Pijuan Galito ́, and C. Annerén, PLOS one, 2013, 
8, e81156 
7 (a) G. Chen, D. R. Gulbranson, Z. Hou, J. M. Bolin, V. Ruotti, 
M. D. Probasco, K. Smuga-Otto, S. E. Howden, N. R. Diol, N. E. 
Propson, R. Wagner, G. O. Lee, J. Antosiewicz-Bourget, J. M. 
C. Teng, and J. a Thomson, Nat. Methods, 2011, 8, 424; (b) J.-
C. Yeo and H.-H. Ng, Cell Res., 2013, 23, 20 
8 J. Hanna, A. W. Cheng, K. Saha, J. Kim, C. J. Lengner, and F. 
Soldner, PNAS, 2010, 107, 1 
9 C. B. Ware, A. M. Nelson, B. Mecham, J. Hesson, W. Zhou, E. 
C. Jonlin, A. J. Jimenez-Caliani, X. Deng, C. Cavanaugh, S. 
Cook, P. J. Tesar, J. Okada, L. Margaretha, H. Sperber, M. 
Choi, C. A. Blau, P. M. Treuting, R. D. Hawkins, V. Cirulli, and 
H. Ruohola-Baker, PNAS, 2014, 111, 4484 
10 (a) C. Lengerke and G. Q. Daley, Ann. N. Y. Acad. Sci., 2009, 
1176, 191; (b) A. Di Cristofano, B. Pesce, C. Cordon-Cardo, 
and P. P. Pandolfi, Nat. Genet., 1998, 19, 348 
11 M. Petrini, F. Felicetti, L. Bottero, M. C. Errico, O. Morsilli, A. 
Boe, A. De Feo, and A. Carè, Cancer Cell Int., 2013, 13, 1 
12 (a) J. Kim, J. M. Auerbach, and J. A. Rodriguez-Gomez, 
Nature, 2002, 418, 50; (b) L. M. Bjorklund, R. Sa, S. Chung, T. 
Andersson, I. Yin, C. Chen, L. M. Bjo, K. S. P. Mcnaught, A. 
Brownell, B. G. Jenkins, C. Wahlestedt, K. Kim, and O. 
Isacson, PNAS, 2002, 99, 2344 
13 (a) R. Zhang, H. K. Mjoseng, M. a Hoeve, N. G. Bauer, S. Pells, 
R. Besseling, S. Velugotla, G. Tourniaire, R. E. B. Kishen, Y. 
Tsenkina, C. Armit, C. R. E. Duffy, M. Helfen, F. Edenhofer, P. 
a de Sousa, and M. Bradley, Nat. Commun., 2013, 4, 1335; 
(b) J. R. Klim, L. Li, P. J. Wrighton, M. S. Piekarczyk, and L. L. 
Kiessling, Nat. Methods, 2010, 7, 989 
14 (a) N. Zhang and D. H. Kohn, Birth Defects Res. C. Embryo 
Today, 2012, 96, 63; (b)  A. S. Khalil, A. W. Xie, and W. L. 
Murphy, ACS Chem. Biol., 2014, 9, 45 
15 (a) S. Dey, B. Kellam, M. R. Alexander, C. Alexander, and F. R. 
A. J. Rose, J. Mater. Chem., 2011, 21, 6883; (b)  X. Qian, L. G. 
Villa-Diaz, R. Kumar, J. Lahann, and P. H. Krebsbach, 
Biomaterials, 2014, 35, 9581; (c) X. Chen, A. B. J. Prowse, Z. 
Jia, H. Tellier, T. P. Munro, P. P. Gray, and M. J. Monteiro, 
Biomacromolecules, 2014, 15, 844 
Page 4 of 7Biomaterials Science
Journal Name  COMMUNICATION 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5  
Please do not adjust margins 
Please do not adjust margins 
16 (a) L. Klouda and A. G. Mikos, Eur. J. Pharm. Biopharm., 2008, 
68, 34; (b) M. A. Ward and T. K. Georgiou, Polymers (Basel)., 
2011, 3, 1215 
17 O. O. Akintewe, S. J. DuPont, K. K. Elineni, M. C. Cross, R. G. 
Toomey, and N. D. Gallant, Acta Biomater., 2015, 11, 96 
18 (a) L. Cui, K. Johkura, F. Yue, N. Ogiwara, Y. Okouchi, K. 
Asanuma, and K. Sasaki, J Histochem Cytochem, 2004, 52, 
1447; (b) W. Zhao, X. Ji, F. Zhang, L. Li, and L. Ma, Molecules, 
2012, 17, 6196 
19 Y.-H. Loh, Q. Wu, J.-L. Chew, V. B. Vega, W. Zhang, X. Chen, 
G. Bourque, J. George, B. Leong, J. Liu, K.-Y. Wong, K. W. 
Sung, C. W. H. Lee, X.-D. Zhao, K.-P. Chiu, L. Lipovich, V. a 
Kuznetsov, P. Robson, L. W. Stanton, C.-L. Wei, Y. Ruan, B. 
Lim, and H.-H. Ng, Nat. Genet., 2006, 38, 431 
20 (a) N. Festuccia, R. Osorno, F. Halbritter, V. Karwacki-Neisius, 
P. Navarro, D. Colby, F. Wong, A. Yates, S. R. Tomlinson, and 
I. Chambers, Cell Stem Cell, 2012, 11, 477; (b) W. Shi, H. 
Wang, G. Pan, Y. Geng, Y. Guo, and D. Pei, J. Biol. Chem., 
2006, 281, 23319 
21 K. Ogawa, A. Saito, H. Matsui, H. Suzuki, S. Ohtsuka, D. 
Shimosato, Y. Morishita, T. Watabe, H. Niwa, and K. 
Miyazono, J. Cell Sci., 2007, 120, 55 
22 (a) N. Lenka, Z. J. Lu, P. Sasse, J. Hescheler, and B. K. 
Fleischman, J. Cell Sci. 115, 2002, 1471 (b) L. Yuguo and D. V. 
Schaffer, PNAS, 2013, E5039–E5048 
 
Page 5 of 7 Biomaterials Science
A chemically defined hydrogel HG21, which allows enzyme-free passaging, is a 
substitute for gelatin allowing standardised and inexpensive mESC culture. 
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